A. García-Martínez

发表

Relapses in Patients With Giant Cell Arteritis

M. Alba, M. Cid, J. Hernández-Rodríguez, 2014, Medicine.

Imatinib mesylate inhibits in vitro and ex vivo biological responses related to vascular occlusion in giant cell arteritis

M. Cid, J. Hernández-Rodríguez, M. Segarra, 2007, Annals of the rheumatic diseases.

Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor α and interleukin‐6) in the long‐term followup of patients with giant cell arteritis

M. Cid, J. Hernández-Rodríguez, S. Prieto-González, 2010, Arthritis care & research.

Factors associated with late presentation to the emergency department in patients complaining of chest pain.

Ò. Miró, S. Jiménez, B. Coll-Vinent, 2021, Patient education and counseling.

Influence of previous coronary artery bypass grafting in the difficulty of acute coronary syndrome diagnosis.

Ò. Miró, M. Ortega, B. Coll-Vinent, 2020, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

External validation of an emergency department triage algorithm for chest pain patients

Ò. Miró, C. Mueller, S. Jiménez, 2020, European heart journal. Acute cardiovascular care.

Advances in the diagnosis of large vessel vasculitis.

M. Alba, M. Cid, J. Hernández-Rodríguez, 2015, Rheumatic diseases clinics of North America.

Effect of Glucocorticoid Treatment on Computed Tomography Angiography Detected Large-Vessel Inflammation in Giant-Cell Arteritis. A Prospective, Longitudinal Study

Marcelo Sánchez, M. Alba, M. Cid, 2015, Medicine.

Early improvement of radiological signs of large-vessel inflammation in giant cell arteritis upon glucocorticoid treatment.

M. Cid, S. Prieto-González, P. Arguis, 2013, Rheumatology.

Five clinical conundrums in the management of giant cell arteritis.

M. Cid, J. Hernández-Rodríguez, A. García-Martínez, 2007, Rheumatic diseases clinics of North America.

8 Aortitis and Aortic Aneurysm in Systemic Vasculitis

M. Cid, J. Hernández-Rodríguez, S. Prieto-González, 2017 .

Aortitis and aortic aneurysm in systemic vasculitis

M. Cid, J. Hernández-Rodríguez, S. Prieto-González, 2011 .

Central Nervous System Vasculitis: Still More Questions than Answers

M. Alba, M. Cid, J. Hernández-Rodríguez, 2011, Current neuropharmacology.

The spectrum of vascular involvement in giant‐cell arteritis: clinical consequences of detrimental vascular remodelling at different sites

M. Cid, J. Hernández-Rodríguez, S. Prieto-González, 2009, APMIS. Supplementum.

The Expanding Role of Imaging in Systemic Vasculitis.

F. Lomeña, M. Alba, M. Cid, 2016, Rheumatic diseases clinics of North America.

Authors’ response to the eLetter by Moiseev et al

J. Grau, M. Alba, M. Cid, 2014, Annals of the rheumatic diseases.

OP0206 Diagnostic Performance of PET/CT in Patients with Newly Diagnosed, Biopsy-Proven, Giant-Cell Arteritis. a Prospective, Case-Control Study Using Roc Analysis at Different Vascular Territories

J. Grau, M. Alba, M. Cid, 2013 .

Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis.

D. Colomer, M. Cid, A. Palacín, 2003, Rheumatology.

Small-vessel vasculitis surrounding a spared temporal artery: clinical and pathological findings in a series of twenty-eight patients.

E. Campo, J. Valls-Solé, C. Font, 2001, Arthritis and rheumatism.

A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis.

J. Fernandez-Solà, J. Grau, M. Cid, 2002, Arthritis and rheumatism.

Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis

Mahboob Rahman, J. Grau, M. Cid, 2012, Annals of the rheumatic diseases.

Increased expression of the endothelin system in arterial lesions from patients with giant-cell arteritis: association between elevated plasma endothelin levels and the development of ischaemic events

M. Cid, J. Hernández-Rodríguez, M. Corbera-Bellalta, 2009, Annals of the rheumatic diseases.

Development of Ischemic Complications in Patients With Giant Cell Arteritis Presenting With Apparently Isolated Polymyalgia Rheumatica: Study of a Series of 100 Patients

C. Font, J. Grau, J. Cañete, 2007, Medicine.

Treatment with statins does not exhibit a clinically relevant corticosteroid-sparing effect in patients with giant cell arteritis.

J. Grau, M. Cid, J. Hernández-Rodríguez, 2004, Arthritis and rheumatism.

Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis—a prospective longitudinal study

Mahboob Rahman, S. Visvanathan, G. Hoffman, 2011, Rheumatology.

New therapeutic targets in giant-cell arteritis. Considerations based on the current pathogenic model and the availability of new therapeutic agents.

M. Cid, J. Hernández-Rodríguez, M. Segarra, 2008, Clinical and experimental rheumatology.

Gelatinase expression and proteolytic activity in giant-cell arteritis

J. Grau, M. Cid, J. Hernández-Rodríguez, 2007, Annals of the rheumatic diseases.

Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways

J. Grau, M. Cid, J. Hernández-Rodríguez, 2018, Front. Immunol..

Cytokines and Vascular Inflammation

M. Cid, J. Hernández-Rodríguez, M. Corbera-Bellalta, 2012 .

Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis.

M. Alba, M. Cid, J. Hernández-Rodríguez, 2014, Seminars in arthritis and rheumatism.

Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case–control study

J. Grau, M. Alba, M. Cid, 2014, Annals of the rheumatic diseases.

Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients

M. Alba, S. Unizony, M. Cid, 2017, RMD Open.

Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis

A. Enjuanes, J. Dayer, P. Roux‐Lombard, 2015, Annals of the rheumatic diseases.

Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis

Mahboob Rahman, J. Dayer, P. Roux‐Lombard, 2013, Annals of the rheumatic diseases.

Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant-cell arteritis.

H. Kleinman, M. Hoffman, M. Cid, 2006, Rheumatology.

Sustained spontaneous clinical remission in giant cell arteritis: report of two cases with long-term followup.

J. Grau, M. Cid, J. Hernández-Rodríguez, 2006, Arthritis and rheumatism.

Evaluation of Aortic Inflammation Using Computed Tomographic Angiography: Vasculitis, Atherosclerosis, or Both

J. Grau, M. Alba, M. Cid, 2015, Journal of the American Geriatrics Society.

Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients.

C. Nicolau, P. Paredes, F. Pons, 2008, Arthritis and rheumatism.

Small-vessel vasculitis surrounding an uninflamed temporal artery as a diagnostic criterion for polymyalgia rheumatica: comment on the article by Chatelain et al.

J. Grau, M. Cid, J. Hernández-Rodríguez, 2009, Arthritis & Rheumatism.

Elevated Production of Interleukin-6 Is Associated With a Lower Incidence of Disease-Related Ischemic Events in Patients With Giant-Cell Arteritis: Angiogenic Activity of Interleukin-6 as a Potential Protective Mechanism

Dolors Colomer, D. Colomer, H. Kleinman, 2003, Circulation.

Malignant phyllodes tumor of the breast with predominant chondrosarcomatous differentiation.

F. Vera-Sempere, A. García-Martínez, 2003, Pathology, research and practice.

New approaches in the nutritional treatment of advanced chronic kidney disease.

A. García-Martínez, A. Vega-Martínez, F. Andrés-Pretel, 2021, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation)

M. Alba, M. Cid, J. Hernández-Rodríguez, 2013, Annals of the rheumatic diseases.

Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography

Marcelo Sánchez, J. Grau, M. Cid, 2012, Annals of the rheumatic diseases.

Sex differences in mortality of older adults with falls after emergency department consultation: FALL‐ER registry

B. Coll-Vinent, A. Gil-Rodrigo, S. Aguiló, 2023, Journal of the American Geriatrics Society.

Central Administration of Aminoprocalcitonin Inhibits Food Intake and Stimulates the Hypothalamic‐Pituitary‐Adrenal Axis in Rats via the Corticotrophin‐Releasing Factor System

A. García-Martínez, E. Tavares, R. Maldonado, 2012, Journal of neuroendocrinology.

D. Ruano, J. Vitorica, A. Castaño, 2009, Journal of neurochemistry.

Factors associated with late presentation to the emergency department in patients complaining of chest pain

Ò. Miró, S. Jiménez, B. Coll-Vinent, 2021, Patient Education and Counseling.

Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis

A. Enjuanes, J. Dayer, P. Roux‐Lombard, 2015, Annals of the rheumatic diseases.

Treatment of Large Vessel Vasculitis

M. Alba, M. Cid, J. Hernández-Rodríguez, 2011 .